Papers

Peer-reviewed
Dec, 2011

[Cavernous sinus dural arteriovenous fistulas treated with percutaneous transvenous embolization using liquid material: two case reports].

No shinkei geka. Neurological surgery
  • Masafumi Hiramatsu
  • ,
  • Kenji Sugiu
  • ,
  • Koji Tokunaga
  • ,
  • Ayumi Nishida
  • ,
  • Mitsuo Kuriyama
  • ,
  • Tomohide Maeshiro
  • ,
  • Kaoru Terasaka
  • ,
  • Isao Date

Volume
39
Number
12
First page
1189
Last page
96
Language
Japanese
Publishing type
Research paper (scientific journal)

INTRODUCTION: Percutaneous transvenous embolization (TVE) using coils is a well-established treatment of cavernous sinus dural arteriovenous fistula (CSdAVF). However, it is sometimes difficult to achieve complete occlusion by coil embolization. In these two cases, we were able to obtain complete angiographic obliteration of the fistulas without complications by means of percutaneous TVE using n-butyl-cyanoacrylate (NBCA) after we failed when TVE using coils. Case 1: An 89-year-old woman presented with double vision. She was diagnosed as Barrow type D right CSdAVF draining only to the cortical vein. We treated the patient by TVE using coils, but the microcatheter was withdrawn before complete occlusion was attained. The repositioning of the microcatheter was difficult, so we used 30% NBCA for TVE, and obtained complete obliteration of the fistula. Case 2: An 87-year-old woman presented with right exophthalmos, and chemosis. She was diagnosed as Barrow type C right CSdAVF draining only to the right superior ophthalmic vein with very slow flow. We planned to treat her, using TVE with coils, but we could place only 3 coils and obtained only partial obliteration of the fistula. So we additionally used 25% NBCA for TVE, and obtained complete obliteration of the fistula. CONCLUSION: Compared to TVE using coils, TVE using NBCA gives rise to many problems, but, we can use NBCA as a second option if TVE using coils results in only partial obliteration as in these cases.

Link information
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/22128275
ID information
  • ISSN : 0301-2603
  • Pubmed ID : 22128275
  • SCOPUS ID : 84455171524

Export
BibTeX RIS